BRAINSTORM CELL THERAPEUTICS INC. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Brainstorm Cell Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q2 2024.
  • Brainstorm Cell Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 71.2M shares, a 79.4% increase year-over-year.
  • Brainstorm Cell Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 43.1M shares, a 18% increase from 2022.
  • Brainstorm Cell Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 36.5M shares, a 0.91% increase from 2021.
  • Brainstorm Cell Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 36.2M shares, a 21.2% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 71.2M +31.5M +79.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 64.7M +28M +76.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 43.1M +6.57M +18% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 44.3M +7.76M +21.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 39.7M +3.21M +8.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 36.7M +299K +0.82% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 36.5M +327K +0.91% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 36.5M +189K +0.52% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 36.5M +168K +0.46% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 36.4M +646K +1.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 36.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 36.3M +5.15M +16.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 36.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 35.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 31.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.